Christiana Shaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christiana Shaw has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- Sanda A. Tan
Department of Surgery, University of Florida College of Medicine, Gainesville, Florida
3 shared publications George A. Sarosi
University of Florida Department of Surgery, Gainesville, FL
2 shared publications- Lou Ann Cooper
Office for Educational Affairs, University of Florida College of Medicine, Gainesville, USA
2 shared publications Sanda A. Tan
Division of General Surgery, Department of Surgery, University of Florida, Gainesville, FL, USA
2 shared publications- Stephen R. Grobmyer
Cleveland Clinic, Cleveland, OH, USA.
2 shared publications Ada Assunta
Research Ar cles
1 shared publication
Latest Publications
- Open Access
- 9 October 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (12) , 2341-2349
Factors contributing to persistent rates of contralateral prophylactic mastectomy in breast cancer patients: Examination of 1051 mastectomies across a single health system
The American Society of Breast Surgeons (ASBrS) outlined definitive guidelines for contralateral prophylactic mastectomy (CPM) in 2016. Despite this, rates of CPM have remained steady. The objective of this study was to identify factors contributing to persistent over‐delivery of CPM. Breast cancer patients across 8 hospitals in a single healthcare system from 2014 to 2018 were retrospectively reviewed. The patients were divided according to whether they received nonindicated CPMs versus other mastectomy types. Nonindicated CPM were those procedures not meeting ASBrS consensus guidelines for recommended patients. CPM rate was calculated for each year in the study period. Patient, disease, provider, and system level factors were obtained. Bivariate analysis was used to identify variables for inclusion in a backward multivariable model. A total of 1,051 patients were analyzed. Nonindicated CPM rates by year remained steady throughout the time period (P = .391). In multivariable regression, patient, disease, and provider level factors were associated with odds of undergoing CPM. Every unit increase in age was associated with a 4% reduction in odds of undergoing CPM (CI 0.941‐0.986). Stage 3 breast cancer compared to stage 1 had 53% lower odds of CPM (CI 0.288‐0.757). Implant‐based breast reconstruction had 2.9‐fold higher odds of CPM compared to no reconstruction (CI 1.476‐5.551). No system level factors were statistically significant. CPM rates have not notably decreased since the ASBrS consensus statement with certain patient and provider factors impacting persistent overuse of CPM. These results inform oncologic and reconstructive providers of factors contributing to continued use of a nonindicated procedure.
- 9 October 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (12) , 2341-2349
Open AccessFactors contributing to persistent rates of contralateral prophylactic mastectomy in breast cancer patients: Examination of 1051 mastectomies across a single health system
The American Society of Breast Surgeons (ASBrS) outlined definitive guidelines for contralateral prophylactic mastectomy (CPM) in 2016. Despite this, rates of CPM have remained steady. The objective of this study was to identify factors contributing to persistent over‐delivery of CPM. Breast cancer patients across 8 hospitals in a single healthcare system from 2014 to 2018 were retrospectively reviewed. The patients were divided according to whether they received nonindicated CPMs versus other mastectomy types. Nonindicated CPM were those procedures not meeting ASBrS consensus guidelines for recommended patients. CPM rate was calculated for each year in the study period. Patient, disease, provider, and system level factors were obtained. Bivariate analysis was used to identify variables for inclusion in a backward multivariable model. A total of 1,051 patients were analyzed. Nonindicated CPM rates by year remained steady throughout the time period (P = .391). In multivariable regression, patient, disease, and provider level factors were associated with odds of undergoing CPM. Every unit increase in age was associated with a 4% reduction in odds of undergoing CPM (CI 0.941‐0.986). Stage 3 breast cancer compared to stage 1 had 53% lower odds of CPM (CI 0.288‐0.757). Implant‐based breast reconstruction had 2.9‐fold higher odds of CPM compared to no reconstruction (CI 1.476‐5.551). No system level factors were statistically significant. CPM rates have not notably decreased since the ASBrS consensus statement with certain patient and provider factors impacting persistent overuse of CPM. These results inform oncologic and reconstructive providers of factors contributing to continued use of a nonindicated procedure.
- Open Access
- 18 July 2020
- Published by Wiley in Journal of Surgical Oncology
- Vol. 122 (2) , 108-112
Issue Information ‐ TOC
- 18 July 2020
- Published by Wiley in Journal of Surgical Oncology
- Vol. 122 (2) , 108-112
Open AccessIssue Information ‐ TOC
- 1 November 2018
- Published by Elsevier in Journal of Surgical Education
- Vol. 75 (6) , e68-e71
Gender Diversity in General Surgery Residency Leadership
- 1 November 2018
- Published by Elsevier in Journal of Surgical Education
- Vol. 75 (6) , e68-e71
Gender Diversity in General Surgery Residency Leadership
- 1 January 2018
- Published by Elsevier in The American Journal of Surgery
- Vol. 215 (1) , 191-195
Are the kids alright? Review books and the internet as the most common study resources for the general surgery clerkship
- 1 January 2018
- Published by Elsevier in The American Journal of Surgery
- Vol. 215 (1) , 191-195
Are the kids alright? Review books and the internet as the most common study resources for the general surgery clerkship
- 19 November 2016
- Published by Springer Nature
- p. 143-150
Choosing a Residency Program
- 26 August 2016
- Published by Hindawi Limited in The Breast Journal
- Vol. 22 (6) , 683-687
A Case of a Giant Borderline Phyllodes Tumor Early in Pregnancy Treated with Mastectomy and Immediate Breast Reconstruction
Breast tumors in pregnancy are often times diagnosed at advanced stages secondary to difficulty distinguishing between pathologic from normal physiologic changes. Often benign, phyllodes tumors are rare fibroepithelial stromal tumors of the breast, most commonly diagnosed in the 4th and 5th decades of life. However, these tumors may be characterized by malignancy with metastases in 10% of cases. In this paper, we report a novel case of a young woman presenting at 8 weeks gestation with a large borderline phyllodes tumor. An exceedingly rare condition, with only nine previously reported cases, phyllodes tumors in pregnancy frequently display more aggressive characteristics with larger median tumor size, more malignant potential, and more rapid growth rate. Here, we describe our experience safely and effectively treating this rare condition in a young gravid women with mastectomy and immediate breast reconstruction in the second trimester.
- 26 August 2016
- Published by Hindawi Limited in The Breast Journal
- Vol. 22 (6) , 683-687
A Case of a Giant Borderline Phyllodes Tumor Early in Pregnancy Treated with Mastectomy and Immediate Breast Reconstruction
Breast tumors in pregnancy are often times diagnosed at advanced stages secondary to difficulty distinguishing between pathologic from normal physiologic changes. Often benign, phyllodes tumors are rare fibroepithelial stromal tumors of the breast, most commonly diagnosed in the 4th and 5th decades of life. However, these tumors may be characterized by malignancy with metastases in 10% of cases. In this paper, we report a novel case of a young woman presenting at 8 weeks gestation with a large borderline phyllodes tumor. An exceedingly rare condition, with only nine previously reported cases, phyllodes tumors in pregnancy frequently display more aggressive characteristics with larger median tumor size, more malignant potential, and more rapid growth rate. Here, we describe our experience safely and effectively treating this rare condition in a young gravid women with mastectomy and immediate breast reconstruction in the second trimester.
- 1 September 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 11 (5) , 421-423
Improved Breast Cancer Care Quality Metrics After Implementation of a Standardized Tumor Board Documentation Template
The addition of a documentation template to multidisciplinary breast cancer conferences resulted in increased recorded adherence rates to national guidelines.
- 1 September 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 11 (5) , 421-423
Improved Breast Cancer Care Quality Metrics After Implementation of a Standardized Tumor Board Documentation Template
The addition of a documentation template to multidisciplinary breast cancer conferences resulted in increased recorded adherence rates to national guidelines.
- Open Access
- 29 July 2015
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2015 (7) , rjv093
Cylindroma-like basaloid anal cancer presenting as a large pelvic mass in a patient with ulcerative colitis
Basaloid cancers of the lower gastrointestinal tract are rare. The lack of mucosal involvement of this type of tumor is uncharacteristic and, to our knowledge, has not been described. In addition, the cylindroma-like appearance of this cancer has only a few examples in the literature. A 51-year-old male presented to us with a history of ulcerative colitis (UC) and obstruction of the anal canal. Imaging and colonoscopy revealed an entirely extraluminal tumor. Percutaneous biopsy yielded a diagnosis of cylindroma-like basaloid carcinoma of the anal region. Neoadjuvant chemotherapy and radiation resulted in stable disease by RECIST criteria. Surgical planning ensued, which led to R0 resection of the tumor, total colectomy and end ileostomy for his UC, and reconstruction of the perineal defect with a rectus myocutaneous flap. Surveillance at 6 months demonstrated no evidence of disease.
- 29 July 2015
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2015 (7) , rjv093
Open AccessCylindroma-like basaloid anal cancer presenting as a large pelvic mass in a patient with ulcerative colitis
Basaloid cancers of the lower gastrointestinal tract are rare. The lack of mucosal involvement of this type of tumor is uncharacteristic and, to our knowledge, has not been described. In addition, the cylindroma-like appearance of this cancer has only a few examples in the literature. A 51-year-old male presented to us with a history of ulcerative colitis (UC) and obstruction of the anal canal. Imaging and colonoscopy revealed an entirely extraluminal tumor. Percutaneous biopsy yielded a diagnosis of cylindroma-like basaloid carcinoma of the anal region. Neoadjuvant chemotherapy and radiation resulted in stable disease by RECIST criteria. Surgical planning ensued, which led to R0 resection of the tumor, total colectomy and end ileostomy for his UC, and reconstruction of the perineal defect with a rectus myocutaneous flap. Surveillance at 6 months demonstrated no evidence of disease.
- 1 July 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (4) , 670-673
Integration of Mobile Technology in Educational Materials Improves Participation: Creation of a Novel Smartphone Application for Resident Education
- 1 July 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (4) , 670-673
Integration of Mobile Technology in Educational Materials Improves Participation: Creation of a Novel Smartphone Application for Resident Education